These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12404249)

  • 1. Baclofen effects on esophageal function: a possible therapy for GERD?
    Hasler WL
    Gastroenterology; 2002 Nov; 123(5):1736-7. PubMed ID: 12404249
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-relaxation therapy in GORD.
    Tack J; Sifrim D
    Gut; 2002 Jan; 50(1):6-7. PubMed ID: 11772956
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?
    Wise J; Conklin JL
    Curr Gastroenterol Rep; 2004 Jun; 6(3):213-9. PubMed ID: 15128488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog.
    Lehmann A; Hansson-Brändén L; Kärrberg L
    Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects.
    Lidums I; Lehmann A; Checklin H; Dent J; Holloway RH
    Gastroenterology; 2000 Jan; 118(1):7-13. PubMed ID: 10611148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More pathophysiologically oriented treatment of GORD?
    Boeckxstaens GE; Tytgat GN
    Lancet; 2002 Apr; 359(9314):1267-8. PubMed ID: 11965270
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists.
    Blackshaw LA; Staunton E; Lehmann A; Dent J
    Am J Physiol; 1999 Oct; 277(4):G867-74. PubMed ID: 10516154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen blocks LES relaxation and crural diaphragm inhibition by esophageal and gastric distension in cats.
    Liu J; Pehlivanov N; Mittal RK
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1276-81. PubMed ID: 12388201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs.
    Lehmann A; Antonsson M; Bremner-Danielsen M; Flärdh M; Hansson-Brändén L; Kärrberg L
    Gastroenterology; 1999 Nov; 117(5):1147-54. PubMed ID: 10535878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
    Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
    Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease.
    Kawai M; Kawahara H; Hirayama S; Yoshimura N; Ida S
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):317-23. PubMed ID: 15076634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel, peripherally restricted GABAB receptor agonist lesogaberan (AZD3355) inhibits acid reflux and reduces esophageal acid exposure as measured with 24-h pHmetry in dogs.
    Brändén L; Fredriksson A; Harring E; Jensen J; Lehmann A
    Eur J Pharmacol; 2010 May; 634(1-3):138-41. PubMed ID: 20176012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.
    Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J
    Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transient lower esophageal sphincter relaxation in GERD: will lesogaberan advance the field?
    Falk GW
    Gastroenterology; 2010 Aug; 139(2):377-9. PubMed ID: 20600061
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial.
    Omari TI; Benninga MA; Sansom L; Butler RN; Dent J; Davidson GP
    J Pediatr; 2006 Oct; 149(4):468-74. PubMed ID: 17011315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of baclofen on the acid pocket at the gastroesophageal junction.
    Scarpellini E; Boecxstaens V; Farré R; Bisschops R; Dewulf D; Gasbarrini A; Pauwels A; Blondeau K; Tack J
    Dis Esophagus; 2015 Jul; 28(5):488-95. PubMed ID: 24758736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflux inhibitor drugs: an emerging novel therapy for gastroesophageal reflux disease.
    Dent J
    J Dig Dis; 2010 Apr; 11(2):72-5. PubMed ID: 20402831
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel medical therapies for gastroesophageal reflux disease beyond proton-pump inhibitors.
    Richter JE
    Gastroenterol Clin North Am; 2002 Dec; 31(4 Suppl):S111-6. PubMed ID: 12489476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic response of the lower esophageal sphincter.
    Roling GT; Farrell RL; Castell DO
    Am J Physiol; 1972 Apr; 222(4):967-72. PubMed ID: 5027107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.